SC Grupul Industrial Electrocontact SA (BVB:ECT)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions RON. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Jan 1, 2024	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021
Market Capitalization	7	6	7	5	5	4
Market Cap Growth	20.00%	-4.30%	45.31%	-13.51%	37.04%	-3.57%
Enterprise Value	7	7	7	5	6	4
Last Close Price	0.05	0.04	0.05	0.03	0.04	0.03
PE Ratio	-	-	120.00	1830.74	70.04	-
PS Ratio	11.05	8.69	9.77	8.19	9.85	7.01
PB Ratio	0.53	0.44	0.45	0.31	0.36	0.26
P/TBV Ratio	0.53	0.44	0.45	0.31	0.36	0.26
P/OCF Ratio	-	90.02	-	39.86	66.61	-
EV/Sales Ratio	11.02	9.51	9.93	8.42	10.25	7.42
EV/EBITDA Ratio	-	-	48.52	37.30	27.56	-
EV/EBIT Ratio	-	-	121.88	570.16	68.10	-
Debt / EBITDA Ratio	-	-	0.00	0.00	0.00	-
Asset Turnover	0.04	0.05	0.04	0.04	0.04	0.03
Inventory Turnover	0.02	0.02	0.02	0	0.00	0.02
Quick Ratio	0.49	1.02	1.97	1.39	1.19	0.81
Current Ratio	2.43	2.83	5.14	4.84	4.75	3.78
Return on Equity (ROE)	-8.98%	-3.93%	0.37%	0.02%	0.51%	-2.29%
Return on Assets (ROA)	-5.13%	-2.34%	0.22%	0.03%	0.33%	-1.30%
Return on Capital (ROIC)	-5.61%	-2.45%	0.23%	0.03%	0.34%	-1.39%
Return on Capital Employed (ROCE)	-	-	0.40%	0.10%	0.50%	-
Earnings Yield	-17.74%	-9.04%	0.83%	0.06%	1.43%	-8.98%
Buyback Yield / Dilution	-	0.38%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.